Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2024. For the year, the company expects net sales of ¥6,800 million, operating profit of ¥410 million, profit attributable to owners of parent of ¥350 million and basic earnings per share of ¥6.98.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
398 JPY | +0.25% | +2.58% | +31.35% |
1st Jan change | Capi. | |
---|---|---|
+31.35% | 127M | |
+20.37% | 43.54B | |
+18.30% | 21.78B | |
+18.88% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-14.84% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024